血浆置换治疗视神经炎的视觉结局:一项纳入395次视神经炎发作的国际多中心回顾性分析
这项国际多中心回顾性研究评估了血浆置换(PLEX)治疗视神经炎(ON)的效果,共纳入317例患者的395次ON发作,并与视神经炎治疗试验(ONTT)的匹配子集比较。多数ON发作经PLEX后视力改善,最终视力差于20/40的比例在PLEX组为6/50(12%),显著低于ONTT中仅用静脉甲泼尼龙组的7/19(37%)(P = .04)。基线视力差、年龄较大和PLEX延迟较长预示结局较差,而MOGAD相关ON预后较好。
要点
- 395次ON发作经PLEX后中位最终视力为20/25(IQR 20/20-20/60),仅MOGAD-ON结局更好。
- 20.5%(81/395)的ON发作最终视力为20/200或更差。
- 与ONTT匹配子集相比,PLEX组最终视力差于20/40的比例为6/50(12%),低于ONTT的7/19(37%)(P = .04)。
核心结论
- 多数ON发作经PLEX后改善,结局优于ONTT中严重程度相似的发作。
- PLEX时视力严重丧失、年龄较大和PLEX延迟较长预示结局较差,而MOGAD-ON预后更有利。
研究设计与样本
- 国际多中心回顾性研究,评估317例患者的395次ON发作经PLEX治疗的结局。
- 结局与视神经炎治疗试验(ONTT)的原始数据匹配子集进行比较。
主要发现
- 患者中位年龄37岁(范围9-75),71%为女性。
- ON病因包括多发性硬化(108次)、MOG抗体相关疾病(MOGAD)(92次)、AQP4-IgG阳性NMOSD(75次)、血清阴性NMOSD(34次)、特发性(83次)和其他(3次)。
- 从视力丧失起病至PLEX的中位时间为2.6周(IQR 1.4-4.0)。
- PLEX时中位视力为数指(IQR 20/200-手动),中位最终视力为20/25(IQR 20/20-20/60),除MOGAD-ON结局更好外,各病因间无差异。
- 81次(20.5%)ON发作最终视力为20/200或更差;结局差的患者年龄更大(P = .002)、PLEX时视力更差(P < .001)、PLEX延迟更长(P < .001)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the effectiveness of plasma exchange (PLEX) for optic neuritis (ON). METHODS: We conducted an international multicenter retrospective study evaluating the outcomes of ON following PLEX. Outcomes were compared to raw data from the Optic Neuritis Treatment Trial (ONTT) using a matched subset. RESULTS: A total of 395 ON attack treated with PLEX from 317 patients were evaluated. The median age was 37 years (range 9-75), and 71% were female. Causes of ON included multiple sclerosis (108), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) (92), aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder (AQP4+NMOSD) (75), seronegative-NMOSD (34), idiopathic (83), and other (3). Median time from onset of vision loss to PLEX was 2.6 weeks (interquartile range [IQR], 1.4-4.0). Median visual acuity (VA) at the time of PLEX was count fingers (IQR, 20/200-hand motion), and median final VA was 20/25 (IQR, 20/20-20/60) with no differences among etiologies except MOGAD-ON, which had better outcomes. In 81 (20.5%) ON attacks, the final VA was 20/200 or worse. Patients with poor outcomes were older (P = .002), had worse VA at the time of PLEX (P < .001), and longer delay to PLEX (P < .001). In comparison with the ONTT subset with severe corticosteroid-unresponsive ON, a final VA of worse than 20/40 occurred in 6 of 50 (12%) PLEX-treated ON vs 7 of 19 (37%) from the ONTT treated with intravenous methylprednisolone without PLEX (P = .04). CONCLUSION: Most ON attacks improved with PLEX, and outcomes were better than attacks with similar severity in the ONTT. The presence of severe vision loss at nadir, older age, and longer delay to PLEX predicted a worse outcome whereas MOGAD-ON had a more favorable prognosis. NOTE: Publication of this article is sponsored by the American Ophthalmological Society.
引用
- Chen JJ, Flanagan EP, Pittock SJ, et al. Visual Outcomes Following Plasma Exchange for Optic Neuritis: An International Multicenter Retrospective Analysis of 395 Optic Neuritis Attacks. Am J Ophthalmol. 2023. PMID: 36822570. doi:10.1016/j.ajo.2023.02.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。